Omada expects to continue to grow revenue at least 20% annually, and updates long-term non-GAAP gross margin target to 80% and adjusted EBITDA margin target to 30%
Duffy exercised options at $9.18 per share and sold under a pre-established Rule 10b5-1 trading plan adopted in March, maintaining over 1.2 million shares through direct and indirect holdings.
Omada Health (NASDAQ:OMDA) highlighted record second-quarter revenue and margin performance at the Canaccord Genuity Growth Conference, while outlining its strategy to expand across cardiometabolic conditions, deepen channel partnerships and use GLP-1-related demand to broaden customer relationships
Omada Health (NASDAQ:OMDA) reported record second-quarter results for 2026, citing broad-based growth across its cardiometabolic programs, expanding channel partnerships and lower costs to serve members. The company also announced that President Wei-Li Shao will succeed Co-founder and Chief Executiv
SAN FRANCISCO, Aug. 06, 2026 (GLOBE NEWSWIRE) -- Omada Health, Inc. (Nasdaq: OMDA), the virtual between-visit healthcare provider, today reported financial results for the second quarter ended June 30, 2026. Omada Health also announced co-founder and CEO Sean Duffy will transition to Founder and Executive Chair effective January 1, 2027, with President Wei-Li Shao assuming the role of CEO.
SAN FRANCISCO, July 23, 2026 (GLOBE NEWSWIRE) -- Omada Health (Nasdaq: OMDA), the virtual between-visit healthcare provider, today announced that it will release its second quarter 2026 results on Thursday, August 6, 2026, after market close, and host a conference call to review the results at 4:30 pm ET the same day.
SAN FRANCISCO, July 23, 2026 (GLOBE NEWSWIRE) -- Omada Health (Nasdaq: OMDA), the virtual between-visit healthcare provider, today announced that it will release its second quarter 2026 results on Thursday, August 6, 2026, after market close, and host a conference call to review the results at 4:30 pm ET the same day.
SAN FRANCISCO, July 15, 2026 (GLOBE NEWSWIRE) -- Omada Health (Nasdaq: OMDA), the virtual between-visit healthcare provider, today announced that members of senior management will host its first Investor Day on Thursday, September 10, 2026. The half‑day, in‑person event will take place in New York City and begin at 1:00 pm EDT.
SAN FRANCISCO, July 13, 2026 (GLOBE NEWSWIRE) -- Omada Health (Nasdaq: OMDA), the virtual between-visit healthcare provider, today announced that members of senior management will participate in Canaccord Genuity’s 46th annual Growth Conference, taking place in Boston, including a fireside chat on Tuesday, August 11, at 8:00 a.m. EDT. The webcast will be available online at https://investors.omadahealth.com/news-events/events. A replay will also be available at the same link following the event.
SAN FRANCISCO, May 27, 2026 (GLOBE NEWSWIRE) -- Omada Health (Nasdaq: OMDA), the virtual between-visit healthcare provider, today announced that members of senior management will participate in the Goldman Sachs 47th Annual Global Healthcare Conference 2026, taking place in Miami, including a fireside chat on Wednesday, June 10, at 8:20 a.m. PST. The webcast will be available online at https://investors.omadahealth.com/news-events/events. A replay will also be available at the same link following the event.
Omada Health (NASDAQ:OMDA) reported what executives described as a “milestone quarter” for the first quarter of 2026, highlighting 42% year-over-year revenue growth, expanding margins, and positive adjusted EBITDA alongside a raised full-year outlook.
On the earnings call, Co-Founder and CEO Sean D
Survey of more than 3,000 GLP‑1 patients reveals care gaps and rising out‑of‑pocket costs, underscoring employers’ need to pair flexible GLP‑1 access with ongoing lifestyle support
